Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 1
1996 1
1998 1
1999 3
2000 6
2001 4
2002 7
2003 3
2004 7
2005 4
2006 3
2007 3
2008 3
2009 5
2010 4
2011 2
2012 5
2013 8
2014 6
2015 2
2016 2
2017 2
2018 5
2019 6
2020 3
2021 4
2022 2
2024 2
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study.
Rossi A, Mari E, Scarno M, Garelli V, Maxia C, Scali E, Iorio A, Carlesimo M. Rossi A, et al. Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):1167-73. doi: 10.1177/039463201202500435. Int J Immunopathol Pharmacol. 2012. PMID: 23298508 Free article. Clinical Trial.
The objective of this open label study is to determine the effectiveness of Serenoa repens in treating male androgenetic alopecia (AGA), by comparing its results with finasteride. ...We can summarize our results by observing that Serenoa repens could l …
The objective of this open label study is to determine the effectiveness of Serenoa repens in treating male androgenetic alope …
Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis.
Trivisonno LF, Sgarbossa N, Alvez GA, Fieiras C, Escobar Liquitay CM, Jung JH, Franco JVA. Trivisonno LF, et al. Investig Clin Urol. 2021 Sep;62(5):520-534. doi: 10.4111/icu.20210254. Investig Clin Urol. 2021. PMID: 34488251 Free PMC article.
PURPOSE: To assess the effects of Serenoa repens alone or in combination with other phytotherapy compared to placebo in men with LUTS due to benign prostatic enlargement. ...The results on quality of life and adverse events are also very uncertain. CONCLUSIONS: S. …
PURPOSE: To assess the effects of Serenoa repens alone or in combination with other phytotherapy compared to placebo in men wi …
Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
Cai T, Cui Y, Yu S, Li Q, Zhou Z, Gao Z. Cai T, et al. Am J Mens Health. 2020 Mar-Apr;14(2):1557988320905407. doi: 10.1177/1557988320905407. Am J Mens Health. 2020. PMID: 32274957 Free PMC article.
Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic hyperplas …
Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out …
Serenoa repens for benign prostatic hyperplasia.
Tacklind J, MacDonald R, Rutks I, Wilt TJ. Tacklind J, et al. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. PMID: 19370565 Free PMC article. Updated.
The main outcome measure for comparing the effectiveness of Serenoa repens with placebo or other interventions was the change in urologic symptom-scale scores. ...AUTHORS' CONCLUSIONS: Serenoa repens was not more effective than placebo for treatment of …
The main outcome measure for comparing the effectiveness of Serenoa repens with placebo or other interventions was the change …
Serenoa repens for benign prostatic hyperplasia.
Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ. Tacklind J, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2023 Jun 22;6:CD001423. doi: 10.1002/14651858.CD001423.pub4. PMID: 23235581 Free PMC article. Updated.
The extract of the berry of the American saw palmetto, or dwarf palm plant, Serenoa repens (SR), which is also known by its botanical name of Sabal serrulatum, is one of several phytotherapeutic agents available for the treatment of BPH. ...AUTHORS' CONCLUSIONS: …
The extract of the berry of the American saw palmetto, or dwarf palm plant, Serenoa repens (SR), which is also known by its bo …
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials.
Paulis G, Paulis A, Perletti G. Paulis G, et al. Arch Ital Urol Androl. 2021 Dec 21;93(4):475-480. doi: 10.4081/aiua.2021.4.475. Arch Ital Urol Androl. 2021. PMID: 34933534 Free article.
BACKGROUND: Serenoa repens (SR) is a plant used to treat benign prostatic hyperplasia and prostatitis. ...
BACKGROUND: Serenoa repens (SR) is a plant used to treat benign prostatic hyperplasia and prostatitis. ...
Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
Russo GI, Scandura C, Di Mauro M, Cacciamani G, Albersen M, Hatzichristodoulou G, Fode M, Capogrosso P, Cimino S, Marcelissen T, Cornu JN, Gacci M, Minervini A, Cocci A; European Association of Urology Young Academic Urologists (EAU-YAU) Men’s Health and Functional Urology Working Groups. Russo GI, et al. Eur Urol Focus. 2021 Mar;7(2):420-431. doi: 10.1016/j.euf.2020.01.002. Epub 2020 Jan 15. Eur Urol Focus. 2021. PMID: 31952967
CONTEXT: International guidelines do not make any specific recommendations on Serenoa repens (SeR) for the treatment of male lower urinary tract symptoms (LUTS) secondary to benign prostatic enlargement (BPE), due to product heterogeneity and methodological limitati …
CONTEXT: International guidelines do not make any specific recommendations on Serenoa repens (SeR) for the treatment of male l …
[Efficacy and safety of Serenoa repens extract combined with alpha-receptor blocker in the treatment of benign prostatic hyperplasia].
Zong HT, Wang XY, Wang T, Zhou X, Zhang Y. Zong HT, et al. Zhonghua Nan Ke Xue. 2019 Jun;25(6):553-558. Zhonghua Nan Ke Xue. 2019. PMID: 32223093 Chinese.
OBJECTIVE: To evaluate the effect and safety of Serenoa repens extract (SR) combined with alpha-receptor blocker (alphaRB) in the treatment of BPH. ...Compared with the patients treated by alphaRB monotherapy, those of the SR+alphaRB group showed significant decreas …
OBJECTIVE: To evaluate the effect and safety of Serenoa repens extract (SR) combined with alpha-receptor blocker (alphaRB) in …
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon( ) ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.
Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, Castro Díaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero García JM, Fernández-Pro Ledesma A, Cózar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V. Vela-Navarrete R, et al. BJU Int. 2018 Dec;122(6):1049-1065. doi: 10.1111/bju.14362. Epub 2018 Jun 6. BJU Int. 2018. PMID: 29694707 Free article.
OBJECTIVES: To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, Permixon( ) ; Pierre Fabre Medicament, Castres, France), at a dose of 320 mg daily, as monotherapy for the treatment of lower urinary tract symptoms assoc …
OBJECTIVES: To comprehensively evaluate the efficacy and safety of the hexanic extract of Serenoa repens (HESr, Permixon( ) ; …
104 results